Agenus
AGEN
#9145
Rank
C$0.18 B
Marketcap
C$4.35
Share price
-11.73%
Change (1 day)
-17.79%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2025 (TTM): C$27.55 Million

According to Agenus 's latest financial reports the company's current earnings are C$0.10 Billion. In 2024 the company made an earning of -C$0.16 Billion, an increase over its 2023 earnings that were of -C$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$27.55 M-117.46%
2024 -C$0.16 Billion-28.13%
2023 -C$0.22 Billion-5.5%
2022 -C$0.24 Billion-556.26%
2021 C$50.91 M-130.37%
2020 -C$0.17 Billion73.75%
2019 -C$96.49 Million-48.74%
2018 -C$0.19 Billion34.32%
2017 -C$0.15 Billion-7.16%
2016 -C$0.16 Billion26.55%
2015 -C$0.12 Billion110.24%
2014 -C$56.74 Million49.12%
2013 -C$38.05 Million
2011 -C$26.27 Million-12.25%
2010 -C$29.94 Million-21.41%
2009 -C$38.1 Million-26.86%
2008 -C$52.09 Million13.72%
2007 -C$45.8 Million-33.4%
2006 -C$68.77 Million-31.84%
2005 -C$0.11 Billion9.74%
2004 -C$91.93 Million-0.8%
2003 -C$92.68 Million17.37%
2002 -C$78.96 Million37.83%
2001 -C$57.29 Million55.99%
2000 -C$36.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$35.75 B 125,627.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.09 B 63,550.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.20 B 46,345.34%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$13.77 B 48,350.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-C$0.4 Billion-1,490.73%๐Ÿ‡บ๐Ÿ‡ธ USA